Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.
about
An Observational Cohort Study of Clostridium difficile Ribotype 027 and Recurrent Infection.Impact of the use of local fidaxomicin treatment algorithms for managing Clostridium difficile infection in hospitalized patients in southeastern United StatesHospital readmission with Clostridium difficile infection as a secondary diagnosis is associated with worsened outcomes and greater revenue loss relative to principal diagnosis: A retrospective cohort study
P2860
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Fidaxomicin for treatment of C ...... a French University Hospital.
@en
Fidaxomicin for treatment of C ...... a French University Hospital.
@nl
type
label
Fidaxomicin for treatment of C ...... a French University Hospital.
@en
Fidaxomicin for treatment of C ...... a French University Hospital.
@nl
prefLabel
Fidaxomicin for treatment of C ...... a French University Hospital.
@en
Fidaxomicin for treatment of C ...... a French University Hospital.
@nl
P2093
P2860
P1433
P1476
Fidaxomicin for treatment of C ...... a French University Hospital.
@en
P2093
Bruno Grandbastien
Clément Charlet
Fanny Loeuillet
Frédéric Wallet
Marie Pichenot
Rozenn Héquette-Ruz
Sophie Schiettecatte
Tatiana Galperine
P2860
P2888
P304
P356
10.1007/S15010-017-0981-8
P577
2017-01-24T00:00:00Z